Detalhe da pesquisa
1.
Could senescence phenotypes strike the balance to promote tumor dormancy?
Cancer Metastasis Rev
; 42(1): 143-160, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36735097
2.
Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment.
Breast Cancer Res
; 20(1): 115, 2018 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30285883
3.
Medical students' ability to diagnose common dermatologic conditions in skin of color.
J Am Acad Dermatol
; 83(3): 957-958, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32017947
4.
Breast cancer cells survive chemotherapy by activating targetable immune-modulatory programs characterized by PD-L1 or CD80.
Nat Cancer
; 3(12): 1513-1533, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36482233
5.
TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines.
Trends Cancer
; 6(2): 98-110, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32061310
6.
BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.
Cell Death Differ
; 27(11): 3097-3116, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32457483
7.
Analysis across multiple tumor types provides no evidence that mutant p53 exerts dominant negative activity.
NPJ Precis Oncol
; 3: 1, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30623031
8.
Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival.
J Cell Biol
; 218(11): 3827-3844, 2019 11 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31530580